Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
World J Pediatr ; 19(5): 460-468, 2023 May.
Artigo em Inglês | MEDLINE | ID: mdl-36598742

RESUMO

BACKGROUND: The survival of preterm infants has improved over the last decade, but impaired brain development leading to poor neurological outcomes is still a major comorbidity associated with prematurity. The aim of this study was to evaluate the effect of nutrition on neurodevelopment in preterm infants and identify markers for improved outcomes. METHODS: Totally 67 premature infants with a gestational age of 24-34 weeks and a birth weight of 450-2085 g were included. Clinical parameters and documented diet were collected from medical records. The nutritional analysis comprised the protein, fat, carbohydrate, and energy intake during different time spans. Brain development was assessed by determining deep gray matter (DGM; basal ganglia and thalamus) and lateral ventricular (LV) volumes as measured on cerebral magnetic resonance imaging scans obtained at term-equivalent age (TEA), and potential associations between nutrition and brain volumetrics were detected by regression analysis. RESULTS: We observed a negative correlation between mean daily protein intake in the third postnatal week and MRI-measured DGM volume at TEA (P = 0.007). In contrast, head circumference at a corrected age of 35 weeks gestation (P < 0.001) and mean daily fat intake in the fourth postnatal week (P = 0.004) were positively correlated with DGM volume. Moreover, mean daily carbohydrate intake in the first postnatal week (P = 0.010) and intraventricular hemorrhage (P = 0.003) were revealed as independent predictors of LV volume. CONCLUSION: The study emphasizes the importance of nutrition for brain development following preterm birth.


Assuntos
Recém-Nascido Prematuro , Nascimento Prematuro , Lactente , Feminino , Recém-Nascido , Humanos , Substância Cinzenta , Nascimento Prematuro/patologia , Encéfalo/diagnóstico por imagem , Idade Gestacional , Imageamento por Ressonância Magnética/métodos
2.
Ital J Pediatr ; 46(1): 179, 2020 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-33261643

RESUMO

BACKGROUND: Iatrogenic severe hyperglycemia (ISH) caused by glucose-containing i.v. solution is a potentially fatal treatment error. The objective of this study was to investigate the causes, circumstances, course of disease, and complications of ISH > 300 mg/dl (16.7 mmol/l) in neonates and children. METHODS: We emailed a survey to 105 neonatal and pediatric intensive care units in Germany, Austria, and Switzerland, asking to retrospectively report cases of ISH. RESULTS: We received 11 reports about premature infants to children. Four patients (36%) had poor outcome: 2 died and 2 suffered persistent sequelae. The highest observed blood glucose was at median 983 mg/dl (54.6 mmol/l) (range 594-2240 mg/dl; 33.0-124.3 mmol/l) and median time to normoglycemia was 7 h (range 2-23). Blood glucose was higher and time to normoglycemia longer in patients with poor outcome. Invasive therapy was required in 73% (mechanical ventilation) and 50% (vasopressor therapy) of patients, respectively. Administration of insulin did not differ between outcome groups. Patients with poor outcome showed coma (100% vs. 40%) and seizures (75% vs. 29%) more frequently than those with good outcome. CONCLUSIONS: ISH is a severe condition with high morbidity and mortality. Further research to amplify the understanding of this condition is needed, but focus should largely be held on its prevention.


Assuntos
Glucose/efeitos adversos , Hiperglicemia/epidemiologia , Hiperglicemia/etiologia , Doença Iatrogênica , Infusões Parenterais/efeitos adversos , Edulcorantes/efeitos adversos , Glicemia/análise , Europa (Continente)/epidemiologia , Feminino , Glucose/administração & dosagem , Humanos , Hiperglicemia/terapia , Lactente , Recém-Nascido , Unidades de Terapia Intensiva Pediátrica , Masculino , Respiração Artificial/estatística & dados numéricos , Estudos Retrospectivos , Edulcorantes/administração & dosagem , Vasoconstritores/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...